Investigation of the Effect of muSic on the Stress of Preterm neONates Through innovATive Applications (SONATA)
SONATA
1 other identifier
interventional
70
1 country
2
Brief Summary
The goal of this prospective randomized clinical trial is to investigate the effect of music intervention on the stress of live born preterm neonates requiring admission to a Neonatal Intensive Care Unit, through the measurements of salivary biomarkers (hormones and proteins). The main question it aims to answer is: Can the daily music intervention reduce the stress levels created by the Neonatal Intensive Care Unit environment in preterm neonates? Researchers will compare preterm neonates who will not be exposed to music intervention to investigate potential discrepancies in salivary stress biomarkers. Participants will be exposed to recorded music for 5 consecutive days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 27, 2024
CompletedFirst Posted
Study publicly available on registry
October 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
April 1, 2025
July 1, 2024
2 years
September 27, 2024
March 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Salivary stress biomarker 1 - Hormone
Concentration of the hormone (Units: μg/dL).
From enrollment to 5 consecutive days.
Salivary stress biomarker 2 - Enzyme
Concentration of the enzyme (Units: U/L).
From enrollment to 5 consecutive days.
Salivary stress biomarker 3 - Protein
Concentration of the protein (Units: μg/mL).
From enrollment to 5 consecutive days.
Secondary Outcomes (8)
Heart rate
Measured before, during, and after each music session daily. From enrollment to the end of intervention at 5 days.
Respiratory rate
Measured before, during, and after each music session daily. From enrollment to the end of intervention at 5 days.
Oxygen saturation
Measured before, during, and after each music session daily. From enrollment to the end of intervention at 5 days.
Blood pressure
Measured before, during, and after each music session daily. From enrollment to the end of intervention at 5 days.
Weight
Measured daily, with cumulative weight gain assessed at the end of the 5 days.
- +3 more secondary outcomes
Study Arms (2)
Standard of care
NO INTERVENTIONPreterm neonates will receive standard of care.
Music intervention
EXPERIMENTALPreterm neonates will be exposed to recorded music intervention. Recorded music will be played through a portable Bluetooth speaker (3.1 watt) placed in the incubator, which will be activated and controlled via a smartphone.
Interventions
Eligibility Criteria
You may qualify if:
- Born between 28 - 36+6 weeks of gestation
- Absence of active infection including blood, urine, cerebrospinal fluid
- Absence of congenital and genetic disorders and chromosomal abnormalities
- Absence of nuclear jaundice
- Absence of endocrine disorders
- Absence of maternal use of illicit drugs prenatally
- Non - sedated neonates
- Positive bilateral transient evoked otoacoustic emissions
- Stable clinical condition
- Absence of brain injury
You may not qualify if:
- Diagnosis of brain injury after the enrollment
- Negative auditory brainstem response before discharge
- Clinical deterioration
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of West Atticalead
- General and Maternity Hospital of Athens Elena Venizeloucollaborator
- Attikon Hospitalcollaborator
Study Sites (2)
General and Maternity Hospital of Athens Elena Venizelou
Athens, 11521, Greece
Attikon General University Hospital
Chaïdári, 12462, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 27, 2024
First Posted
October 21, 2024
Study Start
July 1, 2024
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
April 1, 2025
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning 1 year after publication with no end date.
- Access Criteria
- Access to de-identified individual participant data (IPD) will be granted to qualified researchers upon reasonable request. Interested parties/research groups must submit a written proposal outlining the intended purpose, type of analysis to be conducted, and justification for access to the data. Data sharing will require the execution of a formal Data Sharing Agreement (DSA) to ensure data use is consistent with ethical and legal standards, including participant confidentiality and proper data handling. Requests will be reviewed by the Principal Investigator and/or a designated review panel. Evaluation will consider the scientific merit of the proposal, qualifications of the requesting researcher(s), and ethical considerations. Communication and submission of the proposal and signed DSA can be done via email to the Primary Investigator. Please contact the Primary Investigator directly for more information or to initiate a request.
All collected de-identified individual participant data (IPD) may be shared upon reasonable request. Interested researchers may contact the Primary Investigator directly to request access. No external link or public repository will be provided.